Manish R. Patel, DO

Manish Patel, DO, discusses updates in treatment with a PD1 and CTLA-4 inhibitor in non–small cell lung cancer.

Manish Patel, MD, DO, discusses choosing a chemoimmunotherapy regimen for patients with advanced, metastatic non–small cell lung cancer.

Manish Patel, DO, discusses the role of CTLA-4 inhibitors in non–small cell lung cancer.

Manish R. Patel, DO, discusses the safety profile of entrectinib in NTRK fusion–positive solid tumors.

Manish R. Patel, DO, discusses the role of entrectinib in gastrointestinal malignancies.

Manish R. Patel, DO, discusses choosing immunotherapy drugs for patients with non–small cell lung cancer.

Manish R. Patel, DO, discusses current questions and research regarding immunotherapy in non–small cell lung cancer.